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Polymorphous low-grade adenocarcinoma (PLGA) is an entity under the subclassiﬁca-
tion of adenocarcinoma from salivary glands.  We report here a rare case of PLGA with 
suspected metastases to a regional lymph node and the liver, conﬁrmed by magnetic res-
onance imaging and computed tomography.  An 88-year-old Japanese woman complain-
ing of pain in the left mandible, speciﬁcally in the gingiva upon swallowing, was referred 
to our clinical department in July 2003.  The pain in the left mandibular gingiva had 
been noted 10 months before the ﬁrst medical examination.  Oral examination revealed a 
38   30 mm mass forming from the left retromolar region to the glossopalatal arch with 
ulcer.  An incisional biopsy of the mass revealed PLGA.  Histopathologically, tumor cells 
presenting mild atypia showed tubular and cribriform structures.  Immunohistochemi-
cally, the Ki-67 labeling index showed 31% suggesting a potential high-grade malignancy 
of tumor cells.
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Polymorphous low-grade adenocarcinoma (PLGA) 
is an uncommon tumor that usually affects the 
minor salivary gland.  PLGA was described by 
Freedman (1983) under the name of lobular car-
cinoma, and by Batsakis and others (1983) as 
terminal duct carcinoma.  Evans and Batsakis 
(1984) eventually coined the term PLGA. PLGA 
is characterized by infiltrative growth, morpho-
logic diversity and cytologic uniformity.  PLGA 
usually shows several overlapping histological 
patterns with pleomorphic adenoma (PA) and 
adenoid cystic carcinoma (ACC).  PA is benign, 
and its architectural patterns vary, for example, in 
ducts, strands or sheets.  PA has myxochondroid 
stromal features.  The cytologic appearance of 
PA is uniform without atypia.  It is difficult to 
distinguish between PA and PLGA, but PA is not 
inﬁltrative and does not show neurotropism.  On 
the other hand, ACC is malignant and inﬁltrative, 
having a tendency toward neural invasion.  ACC 
has various morphologic patterns that are identi-
ﬁed as cribriform, solid or tubular.  The clinico-
pathological features of PLGA overlap PA and 
ACC and that may result in a diagnostic pitfall. 
The malignancy of PLGA is usually low, and me-
tastases to regional lymph nodes and distant areas 
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are uncommon.  Local recurrence rates of PLGA 
range from 10% to 20% and regional metastases 
are up to 10% on review articles (Gnepp et al., 
1988; Vincent et al., 1994).  Nevertheless, three 
histologically conﬁrmed cases of distant metasta-
ses from PLGA have been reported (Tanaka et al., 
1995; Thomas et al., 1995; Hannen et al., 2000). 
We report here a rare case of PLGA that occurred 
in the retromolar region, suspecting metastases in 
the regional lymph node and liver by computed 
tomography and echography.  In addition, we 
summarize immunohistochemistry and examine a 
potential high-grade malignancy of tumor cells.  
 
Patient Report
Patient
An 88-year-old Japanese woman was referred to 
our clinic at Tottori University Hospital in July 
2003.  She complained of a pain in the left man-
dibular gingiva upon swallowing.  The pain was 
noted 10 months before her first medical exami-
nation.  Oral examination revealed a 38  30 mm 
mass and a 10 mm ulcer at the left retromolar 
region, the palatoglossal arch and the left tonsil 
region (Fig. 1).  T1-weighted magnetic resonance 
image (MRI) revealed an unclear image of a mass 
in the left retromolar region (Fig. 2).  Echography 
revealed a metastasis to the left submandibular 
lymph node.  She also suffered from hypertension 
and type C hepatitis.  Laboratory data showed 
high levels of AFP (13.4 ng/mL) and CA19-9 (71.8 
U/mL), but PIVKA-II was 34 mAU/mL and was 
within normal limits.  A computed tomography 
(CT) scan revealed a uniform low absorption le-
sion, 5 cm in diameter, in S5 region of the liver, 
suggesting liver metastasis (Fig. 3).  Specimens of 
the retromolar region were obtained by incisional 
biopsy.
 
Microscopic features of the tumor
Incisional biopsy was performed.  After being 
fixed in 10% buffered formalin for a day, the 
specimens were embedded in paraffin, and cut 
into 4- to 5-μm thick sections, then stained with 
hematoxylin and eosin.  The tumor was seen just 
under the mucosa and had no capsular element. 
The tumor cells showed mainly tubular and 
cribriform patterns and consisted of isomorphic 
epithelial cells having round to oval nuclei with 
Fig. 1. Clinical ﬁndings of polymorphous low-grade ad-
enocarcinoma (PLGA) in the left retromolar region.
Fig. 2. T1-weighted magnetic resonance image (MRI) 
shows an unclear low signal in the left retromolar region.
Fig. 3. An enhanced computed tomography (CT) scan 
shows a 5-cm space occupying in S5 region of the liver.
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non-promiment nucleoli.  Mitotic features were 
rare.  Necrotic areas and perineural and vascular 
invasion were not observed.  The tumor stroma 
showed hyalinization and myxoid changes with 
focal lymphocyte inﬁltration (Fig. 4A).
 
Immunohistochemistry
The paraffin embedded tissue sections were de-
paraffinized, and sections were blocked with en-
dogenous peroxidase with 0.3% H2O2/methanol. 
They were then incubated at 4˚C overnight with 
the following antibodies: cytokeratin (AE1/AE3), 
vimentin, S-100 protein, carcinoembryonic antigen 
(CEA), alpha smooth muscle actin ( -SMA), glial 
ﬁbrillary acidic protein (GFAP), Ki-67, E-cadherin, 
cyclooxygenase 2 (Cox-2), p53 and vascular endo-
thelial growth factor (VEGF) (Table 1).  Antigens 
reacting with each antibody were ampliﬁed using 
the streptavidin-biotin-peroxidase complex method.
Fig. 4.  Histopathological and immunohistochemical ﬁndings of polymorphous low-grade adenocarcinoma (PLGA).
Table 1.  A summary of the immunostaining of PLGA
    Antibody Source  Dilution  PLGA
Cytokeratin (AE1/AE3) Nichirei (Tokyo, Japan)    1 +
Vimentin  Nichirei (Tokyo, Japan)   1  +
S-100 protein   Nichirei (Tokyo, Japan)    1 +
Carcinoembryonic antigen (CEA)    Nichirei (Tokyo, Japan)   1 Partially +
Alpha smooth muscle actin ( -SMA)   Dako Japan (Kyoto, Japan)  50 –
Glial ﬁbrillary acidic protein (GFAP)    Dako Japan (Kyoto, Japan)   50  –
Ki-67 Dako Japan (Kyoto, Japan)    50  +
E-cadherin Zymed Laboratories (San Francisco, CA)  1 Weak +
Cyclooxygenase 2 (Cox-2) Cyman Chemical (Ann Arbor, MI)  250 –
p53 Dako Japan (Kyoto, Japan)  50   –
Vascular endotherial growth factor (VEGF) Santa Cruz Biotechnolog (Santa Cruz, CA)   150  –
+, positive staining; –, negative staining; PLGA, polymorphous low-grade adenocarcinoma.
A: Hematoxylin and eosin stain.  
  Bar = 50 μm.
B: Vimentin staining.   Bar = 50 μm.
C: GFAP is negative.   Bar = 50 μm.
D: Ki-67 staining.   Bar = 50 μm.
E: E-cadherin staining.   Bar = 30 μm.
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 The tumor was positive for AE1/AE3, vimen-
tin and S-100 protein.  CEA was partially positive. 
Expressions of VEGF, p53, -SMA and GFAP 
were not found (Figs. 4B and C).  The immunore-
activity of cell adhesion molecular E-cadherin was 
low.  The Ki-67 labeling index was 31.3% (Figs. 
4D and E, Table 1).  We diagnosed PLGA by his-
topathology and immunohistochemistry.
 
Treatment
Our patient underwent two runs of chemotherapy, 
CDDP (40 mg/m2)-5-FU (200 mg/m2) by intra-
arterial infusion and external X-ray radiation (6 
MV, 2 Gy/fraction/day, total 50 Gy).  We injected 
the agents into the left lingual and maxillary 
arteries by half doses.  Through this treatment, 
the CT and MRI ﬁndings showed a complete re-
sponse in the primary lesion.  Also, the space-
occupying lesion of the liver was reduced, so she 
underwent hepatic arterial infusion chemotherapy 
with CDDP (20 mg/m2) and 5-FU (610 mg/m2) 
via an implantation port system.  Further three 
courses of chemotherapy were given every week. 
Although the space-occupying lesion of the liver 
could still be visualized by CT scan at 2.7 cm in 
diameter, she was voluntarily discharged.  Six 
months later, she had an additional biopsy per-
formed on her for swelling in the left retromolar 
region, upon which she was given a diagnosis of 
recurrence of PLGA.  The histological pattern of 
the second biopsy specimen was the same as that 
of the ﬁrst incisional biopsy, conﬁrming the diag-
nosis of recurrent PLGA.  She did not want to be 
hospitalized which resulted in her death.
 
Discussion
 
Of minor salivary gland tumors, PLGA accounts 
for 7% to 11% of benign and malignant tumors 
combined, and for 19% to 26% of malignant 
tumors, and it is the second most common af-
ter mucoepidermoid carcinoma (Waldron et al., 
1988; Ellis and Aiclair, 1996).  Though PLGA  is 
thought to be an indolent tumor, three cases of 
PLGA with microscopically confirmed distant 
metastasis have been reported (Tanaka et al., 
1995; Thomas et al., 1995; Hannen et al., 2000).
 Microscopically, PLGA shows histopatho-
logic features characteristic of many benign and 
malignant salivary glands neoplasms, particularly 
several overlapping histological patterns with 
pleomorphic adenoma (PA) and adenoid cystic 
carcinoma (ACC).  It is difﬁcult to conﬁrm PLGA 
only by histopathology, so it is necessary to per-
form immunohistochemical analysis.  To differ-
entiate PLGA from PA immunohistochemically, 
Curran and others (2001) reported that GFAP 
can be a reliable adjunct for distinguishing PLGA 
from PA of minor salivary glands due to the ab-
sence of reactivity to GFAP in the majority of 
PLGA cases.  Actually, GFAP was negative in our 
case.  Also, Darling and others (2002) reported 
that vimentin may be the sole marker allowing a 
distinction between PLGA and ACC due to the 
presence of reactivity to vimentin in the majority 
of PLGA cases.  In our case, vimentin was posi-
tive.  With the above-mentioned techniques, we 
determined the present case to be PLGA.
 Generally, PLGA with a predominantly 
papillary growth pattern has a worse clinical out-
come than in this case (Mitchell et al., 1989).  But 
Evans and Luna (2000) reported that papillary ar-
eas of more than the focal extent were associated 
with cervical lymph-node metastasis to a statisti-
cally significant degree, while this was not true 
of local recurrence and distant metastasis.  In our 
case, tumor growth showed mainly tubular and 
cribriform patterns.  Yet the Ki-67 labeling index, 
a cell proliferation marker, was 31.3% on the ﬁrst 
incisional biopsy.  In previous studies, Simpson et 
al. (2002) reported two cases of PLGA with trans-
formation to high-grade carcinoma, and found 
that the low-grade areas with the Ki-67 labeling 
index of 2% and 3% were typical, in stark con-
trast to 38% and 30% in the high-grade elements. 
E-cadherin was examined in our case.  The cell 
adhesion molecular E-cadherin expression was 
low.  Because of this, we suspected that the pres-
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ent case was proof of a high-grade change, since 
our patient eventually had lymph-node and liver 
metastases, but those metastasized lesions re-
mained bioptically unproven.
 We performed other immunohistochemical 
analyses to confirm our results.  To our knowl-
edge, Cox-2 for PLGA had never been immuno-
histochemically examined previously.  Shibata 
and others (2005) reported that Cox-2 was noted 
in the squamous cell carcinomas (SCCs) preceded 
by dysplasia, but that it was not noted in SCCs not 
preceded by dysplasias.  Therefore, Cox-2 plays 
some role in the early stages of carcinogenesis of 
SCCs.  In our case, the Ki-67 labeling index was 
high, and the tumor showed high-grade malig-
nancy.  We thought that Cox-2 participates in the 
change from low-grade to high-grade malignancy 
in the malignant salivary gland tumors.  We tried 
to analyze Cox-2 in this case immunohistochemi-
cally, but the result was negative.  It is necessary 
to examine the result furthermore in the future.
 PLGA has low-grade malignancy.  In treat-
ing PLGA surgically, PLGA is locally excised in a 
wide fashion including the invaded surgical mar-
gins.  This procedure seems acceptable after full 
evaluation of the surgical margins and when fol-
lowed by radiation therapy (Vincent et al., 1994; 
Gonzalez-Garcia et al., 2005).  But there is no ev-
idence that indicates any beneﬁt from postopera-
tive radiation or adjuvant chemotherapy, although 
both modalities have been used (Ellis and Aiclair, 
1996).  PLGA is indolent in many cases, but there 
is a type of high-grade malignancy that metasta-
sizes to other organs.  In our case, we could not 
excise the tumor because the patient being at an 
advanced age did not wish to be surgically man-
aged.  After PLGA was adopted to the subclassiﬁ-
cation of adenocarcinoma by the WHO (1991), re-
view articles on PLGA of high-grade malignancy 
have been reported.  We need to examine more 
cases of PLGA for further considerations.
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